US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Realty Income Corp
NYSE:O
|
Real Estate
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Beijing Strong Biotechnologies Inc
SZSE:300406
Beijing Strong Biotechnologies Inc
PP&E Net
Beijing Strong Biotechnologies Inc
PP&E Net Peer Comparison
Competitive PP&E Net Analysis
Latest Figures & CAGR of Competitors
Company | PP&E Net | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Beijing Strong Biotechnologies Inc
SZSE:300406
|
PP&E Net
ÂĄ555.2m
|
CAGR 3-Years
21%
|
CAGR 5-Years
18%
|
CAGR 10-Years
N/A
|
|
Beigene Ltd
HKEX:6160
|
PP&E Net
ÂĄ9.3B
|
CAGR 3-Years
54%
|
CAGR 5-Years
54%
|
CAGR 10-Years
N/A
|
|
Innovent Biologics Inc
HKEX:1801
|
PP&E Net
ÂĄ4.9B
|
CAGR 3-Years
30%
|
CAGR 5-Years
34%
|
CAGR 10-Years
N/A
|
|
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
|
PP&E Net
ÂĄ2.9B
|
CAGR 3-Years
46%
|
CAGR 5-Years
37%
|
CAGR 10-Years
N/A
|
|
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
|
PP&E Net
ÂĄ5.1B
|
CAGR 3-Years
27%
|
CAGR 5-Years
26%
|
CAGR 10-Years
25%
|
|
Imeik Technology Development Co Ltd
SZSE:300896
|
PP&E Net
ÂĄ279.5m
|
CAGR 3-Years
22%
|
CAGR 5-Years
16%
|
CAGR 10-Years
N/A
|
See Also
What is Beijing Strong Biotechnologies Inc's PP&E Net?
PP&E Net
555.2m
CNY
Based on the financial report for Mar 31, 2024, Beijing Strong Biotechnologies Inc's PP&E Net amounts to 555.2m CNY.
What is Beijing Strong Biotechnologies Inc's PP&E Net growth rate?
PP&E Net CAGR 5Y
18%
Over the last year, the PP&E Net growth was 19%. The average annual PP&E Net growth rates for Beijing Strong Biotechnologies Inc have been 21% over the past three years , 18% over the past five years .